P362. Type A Aortic Dissection repair in the presence of pericardial effusion
Presented During: POD Abstracts (Available for viewing in the exhibit hall for the duration of the meeting)
Affiliated Drum Tower Hospital of Nanjing University Medical School
China, Jiangsu
China - Contact Me
Dr. Xue Yunxing graduated from Nanjing Medical University and is currently the deputy chief physician of cardiovascular surgery at Nanjing Drum Tower Hospital in China. Dr. Xue is currently a member of Asian Society of Cardiovascular and Thoracic Surgery and academic secretary of Jiangsu Society of Cardiovascular Surgery (Jiangsu Province of China). Dr. Xue was also Visiting Scholar at the Cardiovascular Center of University of Texas Memorial Hermann Hospital and Cardiac Surgery of Massachusetts General Hospital. Dr. Xue had published over 30 papers included in SCI, the main research areas are aortic surgery and valve surgery.
Thursday, April 25, 2024: 5:38 PM - 7:00 PM
Sheraton Times Square
Room: Central Park
Description
Introduction: Type A Aortic Dissection (TAAD) is a life-threatening disease and in rare cases is complicated by cardiac tamponade. We aimed to investigate the outcomes after TAAD surgery in the presence of pericardial effusion in a large tertiary centre.
Methods: From January 2011 to January 2020, 1406 consecutive patients underwent TAAD repair at our centre. After removing patients with no data on the presence of pericardial effusion, the final dataset included 1098 patients which were divided in two groups: 132 (12%) patients presented with signs of pericardial effusion and represented the study group.
Results: The median age was 52 years (IQR: 44 -62) and 26% of the patients were female. Compared with the non-effusion patients, the study group patients were older (median age 57 years vs 52, p <0.01) and presented with lower systolic blood pressure (median 116 vs 136 mmHg, p < 0.01) and higher heart rate (median HR 86 vs 80 bpm, p < 0.01). They also had more signs of peripheral malperfusion such as preoperative stroke (22% vs 8.3%), hemiplegia (4.5% vs 1%), limb ischaemia (22% vs 14%) and alterations of the consciousness (7.6% vs 1.1%). The postoperative outcomes were also worst in these patients with a higher in hospital mortality (29% vs 12%) and prolonged ventilations time (median 44 vs 27 hours).
Conclusion: Pericardial effusion and cardiac tamponade in the presence of TAAD represent life-threatening conditions with significant negative impact on the preoperative clinical status and increased postoperative complications and mortality rates.
Authors
Yunxing Xue (1), Vito Domenico Bruno (2), Fudong Fan (1), JUN PAN (1), Qing Zhou (1), Dongjin Wang (1)
Institutions
(1) Nanjing Drum Tower Hospital, Nanjing, China, (2) IRCCS Galeazzi – Sant’Ambrogio Hospital, Milan, Italy
Methods: From January 2011 to January 2020, 1406 consecutive patients underwent TAAD repair at our centre. After removing patients with no data on the presence of pericardial effusion, the final dataset included 1098 patients which were divided in two groups: 132 (12%) patients presented with signs of pericardial effusion and represented the study group.
Results: The median age was 52 years (IQR: 44 -62) and 26% of the patients were female. Compared with the non-effusion patients, the study group patients were older (median age 57 years vs 52, p <0.01) and presented with lower systolic blood pressure (median 116 vs 136 mmHg, p < 0.01) and higher heart rate (median HR 86 vs 80 bpm, p < 0.01). They also had more signs of peripheral malperfusion such as preoperative stroke (22% vs 8.3%), hemiplegia (4.5% vs 1%), limb ischaemia (22% vs 14%) and alterations of the consciousness (7.6% vs 1.1%). The postoperative outcomes were also worst in these patients with a higher in hospital mortality (29% vs 12%) and prolonged ventilations time (median 44 vs 27 hours).
Conclusion: Pericardial effusion and cardiac tamponade in the presence of TAAD represent life-threatening conditions with significant negative impact on the preoperative clinical status and increased postoperative complications and mortality rates.
Authors
Yunxing Xue (1), Vito Domenico Bruno (2), Fudong Fan (1), JUN PAN (1), Qing Zhou (1), Dongjin Wang (1)
Institutions
(1) Nanjing Drum Tower Hospital, Nanjing, China, (2) IRCCS Galeazzi – Sant’Ambrogio Hospital, Milan, Italy
Presentation Duration
PODS will be on display in the exhibit hall for the duration of the meeting during exhibit hall hours. PODS will also be available for viewing on the meeting website. There is no formal presentation associated with your POD, but we encourage you to visit the PODS area during breaks to connect with those viewing.